Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $18.9300 (-0.79%) ($18.7300 - $19.0900) on Tue. Dec. 17, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.14% (three month average) | RSI | 41 | Latest Price | $18.9300(-0.79%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.3% a day on average for past five trading days. | Weekly Trend | HALO declines -0.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(54%) IWO(54%) IWM(50%) IWC(49%) XBI(49%) | Factors Impacting HALO price | HALO will decline at least -1.07% in a week (0% probabilities). VIXM(-38%) VXX(-20%) UUP(-7%) TLT(-3%) IGOV(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.07% (StdDev 2.14%) | Hourly BBV | 0 () | Intraday Trend | -0.7% | | | |
|
Resistance Level | $19.1 | 5 Day Moving Average | $18.89(0.21%) | 10 Day Moving Average | $19.03(-0.53%) | 20 Day Moving Average | $19.1(-0.89%) | To recent high | -3.1% | To recent low | 26.8% | Market Cap | $2.587b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |